The fibrinolytic activity of alteplase remained at >90% (compared with the standard solution) for the initial 48 hours at 2 °C, regardless of whether the solution had first been frozen (Table 1).

Recent research has revealed compelling evidence supporting tenecteplase as a more effective treatment for ischemic strokes compared to traditional alteplase therapy. This discovery could mark a ...

The activity and sterility of reconstituted alteplase solution and the effectiveness of an alteplase dose-escalation protocol for the clearance of midlinecatheter and central-venous-access device ...